Leprosy and American cutaneous leishmaniasis coinfection-Reference-Cited by-同舟云学术

Leprosy and American cutaneous leishmaniasis coinfection

Published:2018-02 Issue:1 Volume:93 Page:123-125
ISSN:1806-4841
Container-title:Anais Brasileiros de Dermatologia
language:
Short-container-title:An. Bras. Dermatol.

Author:

Mercadante Larissa Mondadori¹,Santos Marcel Alex Soares dos¹,Pegas Elisangela Samartin²,Kadunc Bogdana Victória¹

Affiliation:

1. Universidade Católica de Campinas, Brazil

2. Pontifícia Universidade Católica de Campinas, Brazil

Publisher

FapUNIFESP (SciELO)

Subject

Dermatology

Link

http://www.scielo.br/pdf/abd/v93n1/0365-0596-abd-93-01-0123.pdf

Reference8 articles.

1. Cutaneous leishmaniasis (cl) associated with leprosy: A new and emerging clinicoepidemiological entity observed in the northeast of Brazil;Costa JML;Gaz méd Bahia,2009

2. Diffuse cutaneous leishmaniasis in coexistence with leprosy;Patrao NA;Int J Dermatol,2015

3. Recognizing and managing the immunologic reactions in leprosy;Kamath S;J Am Acad Dermatol,2014

4. Leishmaniose tegumentar americana: estudo clínico, epidemiológico e laboratorial realizado no Hospital Universitário de Campo Grande, Mato Grosso do Sul, Brasil;Murback ND;An Bras Dermatol,2011

5. Tratado de Dermatologia;Belda Júnior W,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IgG seroprevalence of Toxoplasma gondii and Leishmania infantum in leprosy patients: Implications for screening and management of co-infections;Diagnostic Microbiology and Infectious Disease;2024-09

2. Global Dilemma and Needs Assessment Toward Achieving Sustainable Development Goals in Controlling Leishmaniasis;Journal of Epidemiology and Global Health;2024-03-11

3. Bacterial, fungal and parasitic co-infections in leprosy: A scoping review;PLOS Neglected Tropical Diseases;2023-05-22

4. Co-infection and Immunosuppression in Hansen’s Disease;Hansen’s Disease;2023

5. Unwelcome prevalence of leishmaniasis with several other infectious diseases;International Immunopharmacology;2022-09